Concerning the DMD geno- and phenotypes, DMD-iPS1 and DMD-iPS2 (CHB, Boston, MA, USA) were induced in a six-year-old male patient with an identified deletion of exon 45-52 of the dystrophin gene and a clinical DMD phenotype, while DMD3 (UCSD061i-65-1) (UCSD, San Diego, CA, USA) was induced in a 23-year-old male patient with an undisclosed dystrophin mutation, clinical DMD, and a dilated cardiomyopathy phenotype. The gene discussed is DMD; the disease is dilated cardiomyopathy.